Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene.

Journal of molecular neuroscience : MN

Volumn 23, Issue 3, 2004, Pages 225-233

  Lahiri, Debomoy K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

5' UNTRANSLATED REGION; ALZHEIMER DISEASE; ANIMAL; ANIMAL MODEL; ANTIBODY SPECIFICITY; COST; ECONOMICS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOUSE; PROMOTER REGION; REVIEW;

5' UNTRANSLATED REGIONS; ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS E; COSTS AND COST ANALYSIS; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, ANIMAL; NF-KAPPA B; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

MLCS; MLOWN;

EID: 4143097904     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/jmn:23:3:225     Document Type: Review

References (32)